Internal Medicine, Endocrinology, Diabetes, & Metabolism · Indianapolis, IN
NPI
1588745343
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5230 E Stop 11 Rd Ste 150
Indianapolis, IN, 46237
Phone (317) 865-5904
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,542 services
Medicare patients, 2024
463
Average age 72
Drug cost, 2024
$3.4M
7,356 prescriptions
Company payments, 2025
$18.04
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael L Hancock II was code 99214 (office e&m - established), 291 times for 235 patients. In total Michael L Hancock II billed 1,542 services in 19 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 291 | 235 | $76.82 | $22K |
| 83036 Blood Count | Office | 208 | 176 | $9.40 | $1,955 |
| 99214 Office E&M - Established | Facility | 173 | 147 | $70.73 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 153 | 61 | $57.39 | $8,780 |
| 99231 Hospital E&M - Subsequent | Facility | 79 | 39 | $33.84 | $2,673 |
| 95251 Test - Miscellaneous | Office | 62 | 55 | $22.76 | $1,411 |
| 99222 Hospital E&M - Initial | Facility | 52 | 52 | $95.82 | $4,983 |
| 99213 Office E&M - Established | Office | 47 | 46 | $51.56 | $2,423 |
| 95251 Test - Miscellaneous | Facility | 37 | 35 | $25.05 | $927 |
| 99204 Office E&M - New | Office | 24 | 24 | $93.08 | $2,234 |
| 99213 Office E&M - Established | Facility | 23 | 23 | $44.44 | $1,022 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 18 | 17 | $12.23 | $220 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 16 | 15 | $12.23 | $196 |
| 99204 Office E&M - New | Facility | 14 | 14 | $85.16 | $1,192 |
By year: 2022 $79K for 1,759 services; 2023 $80K for 1,607 services; 2024 $71K for 1,542 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 208 | 176 | $9.40 | $1,955 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael L Hancock II prescribed most often to Medicare patients was Levothyroxine Sodium, with 763 prescriptions and refills. In total Michael L Hancock II wrote 7,356 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 763 | 1,848 | 195 | $6,767 |
| Ozempic Semaglutide | 437 | 657 | 104 | $619K |
| Atorvastatin Calcium Generic | 399 | 1,103 | 125 | $3,136 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 363 | 843 | 117 | $68K |
| Mounjaro Tirzepatide | 346 | 499 | 80 | $535K |
| Jardiance Empagliflozin | 338 | 749 | 103 | $435K |
| Metformin Hcl Generic | 261 | 704 | 80 | $2,244 |
| Metformin Hcl Er Metformin Hcl | 247 | 703 | 83 | $2,164 |
| Pioglitazone Hcl Generic | 206 | 568 | 63 | $1,920 |
| Glimepiride Generic | 201 | 560 | 71 | $1,615 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 194 | 464 | 87 | $23K |
| Ezetimibe Generic | 163 | 399 | 51 | $2,579 |
| Farxiga Dapagliflozin Propanediol | 135 | 271 | 37 | $143K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 133 | 185 | 27 | $128K |
| Trulicity Dulaglutide | 121 | 200 | 35 | $189K |
Brand drugs: 3,662 claims; generic drugs: 3,045 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael L Hancock II $18.04 ($18.04 in general payments such as food, travel and fees) from 1 company. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $18.04.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $18.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.